Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report

Report
511 Pages
March 2024
Region: Global
Global Industry Analysts, Inc
ID: 2785211

The global market for Hemoglobin A1C (HbA1C) Testing is estimated at US$1.3 Billion in 2023 and is projected to reach US$2.3 Billion by 2030, growing at a CAGR of 7.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

Market Growth: Understand the significant growth trajectory of the Ion-Exchange High Performance Liquid Chromatography (HPLC) segment, which is expected to reach US$915.7 Million by 2030 with a CAGR of 7.7%. The Immunoassays segment is also set to grow at 8.3% CAGR over the next 8 years.
Regional Analysis: Gain insights into the U.S. market, estimated at $386.6 Million in 2023, and China, forecasted to grow at an impressive 9.2% CAGR to reach $274.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global Hemoglobin A1C (HbA1C) Testing Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Hemoglobin A1C (HbA1C) Testing Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global Hemoglobin A1C (HbA1C) Testing Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 110 Featured):

Abbott Laboratories, Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
ACON Laboratories, Inc.
ARKRAY, Inc.
A. Menarini Diagnostics Srl
Apex Biotechnology Corporation
Axis-Shield Diagnostics Ltd.
Agappe Diagnostics Ltd.
Biorex Diagnostics
Boditech Med, Inc.
Biosurfit SA
Accruex Biomedical Pvt., Ltd.
Ailex Technology Group Co., Ltd.
American Screening Corporation, Inc.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Competition
Hemoglobin A1C (HbA1C) Testing - Global Key Competitors Percentage Market Share in 2022 (E)
Hemoglobin A1C (HbA1C) Testing Competitor Market Share Scenario Worldwide (in %): 2022E
HbA1c Devices: Critical Role in Monitoring & Management of Diabetes
Role of HbA1c Testing in Diabetes Diagnosis and Management
Interpretation of HbA1c in NGSP and IFCC Units as per the American Diabetes Association
Global Market Analysis and Prospects
World Hemoglobin A1C (HBA1C) Testing Market Set to Witness Rapid Growth
While Developed Regions Lead, Asia-Pacific to Spearhead Long-term Growth
Chromatography-based Hb Testing Devices Lead Market
Ion-Exchange HPLC Test for Hemoglobin A1c Makes NoTable Headway as Reliable Diabetes Screening Tool
HPLC Testing for HbA1c Retains Value as Gold Standard
Ion-exchange HPLC Testing: Primary Merits for Different Stakeholders
HbA1c Testing to Witness Skyrocketing Interest with Focus on POC Testing for Diabetes
Diabetes Screening to Receive Special Thrust from Rapid Point-Of-Care HbA1c Testing
Recent Market Activity
WORLD BRANDS
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Ion-Exchange High Performance Liquid Chromatography (HPLC) (Technology) Global Competitor Market Share Positioning for 2022 & 2030

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Increasing Diabetes Prevalence and the Need for Diabetes Management to Prop-up Demand for HbA1c Monitoring Devices
World Diabetes and Population Statistics (2019, 2030 & 2045)
Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
World Diabetes Prevalence (2000-2045P)
Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
Diabetes Emerges as One of the Leading Causes of Mortality
Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region: 2019
Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
Point-of-Care (POC) HbA1c Testing Products/Analyzers of Select Players
Laboratory-based HbA1c Testing Products/Analyzers of Select Players
Major Testing Methods in POC HbA1c Tests
High Risk of Diabetes in Aging Demographics Promises Growth in HbA1c Testing Devices Market
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Increasing Obesity Levels Underpins Market Growth
Average Per Capita Annual Health Expenditure (In US$) due to Obesity
Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
Increasing Healthcare Expenditure Fuels Demand for HbA1c Testing Devices
World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
Variants & Derivatives Affecting Accuracy of HbA1c Testing
Rising Menace of Undiagnosed Diabetes Turns Heads towards Hemoglobin A1c Testing
Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Hemoglobin A1C Testing
Technology Developments Transform Diagnostics in Diabetes Care
Non-Invasive Glucose Meters and Continuous Glucose Monitors Offer Viable Alternative to Hemoglobin A1c Monitoring
Role of Hemoglobin A1C Monitoring in Patients with Chronic Kidney Disease
HbA1C Testing Holds Significance as Screening Strategy for Gestational Diabetes
Home HbA1C Testing Market

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Hemoglobin A1C (HbA1C) Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
Table 2: World Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 3: World Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 4: World 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
Table 5: World Recent Past, Current & Future Analysis for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 6: World Historic Review for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 7: World 16-Year Perspective for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 8: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 9: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 10: World 16-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 11: World Recent Past, Current & Future Analysis for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 12: World Historic Review for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 13: World 16-Year Perspective for Boronate Affinity Chromatography by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 14: World Recent Past, Current & Future Analysis for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 15: World Historic Review for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 16: World 16-Year Perspective for Direct Enzymatic Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 19: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 20: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 21: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 22: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 23: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 24: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 25: World 16-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

UNITED STATES

Market Facts & Figures
US Hemoglobin A1C (HbA1C) Testing Market Share (in %) by Company: 2022 & 2030
Ion-Exchange High Performance Liquid Chromatography (HPLC) (Technology) Market Share Analysis (in %) of Leading Players in the US for 2022 & 2030
Immunoassays (Technology) Competitor Revenue Share (in %) in the US: 2022 & 2030
Boronate Affinity Chromatography (Technology) Market Share Breakdown (in %) of Major Players in the US: 2022 & 2030
Direct Enzymatic Assays (Technology) Market in the US: Percentage Breakdown of Revenues by Company for 2022 & 2030
Market Analytics

CANADAJAPANCHINA

EUROPE

Market Facts & Figures
European Hemoglobin A1C (HbA1C) Testing Market: Competitor Market Share Scenario (in %) for 2022 & 2030
Ion-Exchange High Performance Liquid Chromatography (HPLC) (Technology) Market Share (in %) by Company in Europe: 2022 & 2030
Immunoassays (Technology) Market Share (in %) of Major Players in Europe: 2022 & 2030
Boronate Affinity Chromatography (Technology) Competitor Market Share Analysis (in %) in Europe: 2022 & 2030
Direct Enzymatic Assays (Technology) Market in Europe: Competitor Revenue Share Shift (in %) for 2022 & 2030
Market Analytics

FRANCEGERMANYITALYUNITED KINGDOMSPAINRUSSIAREST OF EUROPEASIA-PACIFICAUSTRALIAINDIASOUTH KOREAREST OF ASIA-PACIFICLATIN AMERICAARGENTINABRAZILMEXICOREST OF LATIN AMERICAMIDDLE EASTIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTAFRICAIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott Laboratories, Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
ACON Laboratories, Inc.
ARKRAY, Inc.
A. Menarini Diagnostics Srl
Apex Biotechnology Corporation
Axis-Shield Diagnostics Ltd.
Agappe Diagnostics Ltd.
Biorex Diagnostics
Boditech Med, Inc.
Biosurfit SA
Accruex Biomedical Pvt., Ltd.
Ailex Technology Group Co., Ltd.
American Screening Corporation, Inc.

Table Information

Report Attribute	Details
No. of Pages	511
Published	March 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 1.3 Billion
Forecasted Market Value ( USD ) by 2030	$ 2.3 Billion
Compound Annual Growth Rate	7.2%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5244EUR$5,450USD£4,437GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€9963EUR$10,355USD£8,429GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15732EUR$16,350USD£13,310GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 110 Featured):

MarketGlass Platform

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Hemoglobin A1c Testing Devices and Kits Market

Global Hemoglobin A1C Testing Market, Forecast to 2028

Global Hemoglobin A1c Analyzer Market by Product (Bench-top Analyzers, Handheld Analyzers, Reagents & Consumables), Technology (Chemical Methods, Separation Methods), Type, Distribution Channel, End User - Forecast 2024-2030

Hemoglobin A1c Testing Devices Global Market Report 2024

Poc Hba1C Testing Global Market Report 2024